While the pathophysiological mechanisms underlying AD are complex, it is noteworthy that inhibition of cell-surface HSP90 has been demonstrated to reduce Toll-like receptor (TLR) signalling in response to pathogen-associated molecular patterns (PAMPs) in human monocytes, suggesting that HSP90 promotes TLR signalling (45). Here, HSP90AA1 is linked to Alzheimer disease.